Skip to Main content Skip to Navigation

Chondrosarcome : mécanismes de résistance aux traitements conventionnels et thérapies innovantes

Abstract : Chondrosarcomas are bone malignant tumors, considered as radio- and chemo-resistant, due to their hypoxic environment. In this context, this study aimed to better understand the role of hypoxia in the resistance of these tumors to chemotherapy (cisplatin) and radiotherapy (X-rays) and to identify new therapeutic strategies to re-sensitize chondrosarcomas by epigenetic targeting of H3K27 methylation. First, we showed that, contrary to what is commonly accepted, hypoxia has differential effect on cisplatin or X-ray sensitivity in chondrosarcomas, while it increases cisplatin resistance and X-ray sensitivity only in one cell line. Secondly, 3-deazaneplanocin A (DZNep) induces apoptosis in these tumors by a mechanism independent of H3K27 methylation and its methylase EZH2 and seems to act through the Rhoβ / EGFR pathway. However, it causes side effects on male fertility. In addition, its association with cisplatin potentiates its toxic effects on chondrosarcomas. The GSK-J4, on the other hand, decreases cell growth and its association with cisplatin increases this effect.This study highlights that chondrosarcomas use different cellular regulation mechanisms, showing the importance of conducting studies on several cell lines in order to better predict the response to treatments. In addition, these studies demonstrate the anti-tumoral properties of DZNep and GSK-J4 in the treatment of these tumors.
Document type :
Complete list of metadatas

Cited literature [560 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Sunday, September 29, 2019 - 1:01:29 AM
Last modification on : Thursday, December 3, 2020 - 6:33:26 PM
Long-term archiving on: : Monday, February 10, 2020 - 3:24:03 AM


Version validated by the jury (STAR)


  • HAL Id : tel-02299931, version 1


Eva Lhuissier. Chondrosarcome : mécanismes de résistance aux traitements conventionnels et thérapies innovantes. Biochimie, Biologie Moléculaire. Normandie Université, 2017. Français. ⟨NNT : 2017NORMC407⟩. ⟨tel-02299931⟩



Record views


Files downloads